{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:44:46Z","timestamp":1790959486672,"version":"4.1.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T00:00:00Z","timestamp":1551830400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Technology Ministry of science and technology support program","award":["2015BAK05B33"],"award-info":[{"award-number":["2015BAK05B33"]}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["HN2015HM066"],"award-info":[{"award-number":["HN2015HM066"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Science and technology project of Henan Province","award":["2015HN15829"],"award-info":[{"award-number":["2015HN15829"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12931-019-1004-3","type":"journal-article","created":{"date-parts":[[2019,3,6]],"date-time":"2019-03-06T10:03:59Z","timestamp":1551866639000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Prognostic value of serum macrophage migration inhibitory factor levels in pulmonary tuberculosis"],"prefix":"10.1186","volume":"20","author":[{"given":"Qingjiang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junmei","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangpeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,3,6]]},"reference":[{"issue":"1","key":"1004_CR1","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1186\/1471-2458-11-110","volume":"11","author":"Y Shao","year":"2011","unstructured":"Shao Y, Yang D, Xu W, et al. Epidemiology of anti-tuberculosis drug resistance in a chinese population: current situation and challenges ahead [J]. BMC Public Health. 2011;11(1):110.","journal-title":"BMC Public Health"},{"key":"1004_CR2","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1016\/S0140-6736(17)33150-1","volume":"390","author":"J Li","year":"2017","unstructured":"Li J, Li T, Du X, et al. The age-structured incidence and mortality of pulmonary tuberculosis reported in China, in 2005\u201315: a longitudinal analysis of national surveillance data [J]. Lancet. 2017;390:S12.","journal-title":"Lancet"},{"key":"1004_CR3","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2471\/BLT.15.154492","volume":"93","author":"HH Lin","year":"2015","unstructured":"Lin HH, Wang L, Zhang H, et al. Tuberculosis control in China: use of modelling to develop targets and policies [J]. Bull World Health Organ. 2015;93:790\u20138.","journal-title":"Bull World Health Organ"},{"issue":"9934","key":"1004_CR4","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0140-6736(13)62639-2","volume":"383","author":"L Wang","year":"2014","unstructured":"Wang L, Zhang H, Ruan Y, et al. Tuberculosis prevalence in China, 1990\u20132010; a longitudinal analysis of national survey data [J]. Lancet. 2014;383(9934):2057\u201364.","journal-title":"Lancet"},{"issue":"23","key":"1004_CR5","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMoa1108789","volume":"366","author":"Y Zhao","year":"2012","unstructured":"Zhao Y, Xu S, Wang L, et al. National survey of drug-resistant tuberculosis in China [J]. N Engl J Med. 2012;366(23):2161\u201370.","journal-title":"N Engl J Med"},{"issue":"1","key":"1004_CR6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/2049-6958-9-11","volume":"9","author":"G Gunluoglu","year":"2014","unstructured":"Gunluoglu G, Yazar EE, Veske NS, et al. Mean platelet volume as an inflammation marker in active pulmonary tuberculosis [J]. Multidiscip Respir Med. 2014;9(1):11.","journal-title":"Multidiscip Respir Med"},{"issue":"959","key":"1004_CR7","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/pgmj.2004.030544","volume":"81","author":"E \u00dcnsal","year":"2005","unstructured":"\u00dcnsal E, Aksaray S, K\u00f6ksal D, et al. Potential role of interleukin 6 in reactive thrombocytosis and acute phase response in pulmonary tuberculosis [J]. Postgrad Med J. 2005;81(959):604\u20137.","journal-title":"Postgrad Med J"},{"issue":"3","key":"1004_CR8","first-page":"238","volume":"55","author":"SS Caner","year":"2007","unstructured":"Caner SS, K\u00f6ksal D, Ozkara S, et al. The relation of serum interleukin-2 and C-reactive protein levels with clinical and radiological findings in patients with pulmonary tuberculosis [J]. Tuberkuloz ve toraks. 2007;55(3):238\u201345.","journal-title":"Tuberkuloz ve toraks"},{"issue":"2","key":"1004_CR9","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s10753-014-9978-y","volume":"38","author":"O Abakay","year":"2015","unstructured":"Abakay O, Abakay A, Sen HS, et al. The relationship between inflammatory marker levels and pulmonary tuberculosis severity [J]. Inflammation. 2015;38(2):691\u20136.","journal-title":"Inflammation"},{"issue":"8","key":"1004_CR10","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/infdis\/jix076","volume":"215","author":"R Ngobeni","year":"2017","unstructured":"Ngobeni R, Abhyankar MM, Jiang NM, et al. Entamoeba histolytica\u2013encoded homolog of macrophage migration inhibitory factor contributes to mucosal inflammation during amebic colitis [J]. J Infect Dis. 2017;215(8):1294\u2013302.","journal-title":"J Infect Dis"},{"issue":"8","key":"1004_CR11","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1164\/rccm.201402-0322OC","volume":"192","author":"M Hiress Le","year":"2015","unstructured":"Le Hiress M, Tu L, Ricard N, et al. Proinflammatory signature of the dysfunctional endothelium in pulmonary hypertension. Role of the macrophage migration inhibitory factor\/CD74 complex [J]. Am J Respir Crit Care Med. 2015;192(8):983\u201397.","journal-title":"Am J Respir Crit Care Med"},{"key":"1004_CR12","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-3083.2007.01958.x","volume":"66","author":"CR Marinho","year":"2007","unstructured":"Marinho CR, Nunez-Apaza LN, Martins-Santos R, Bastos KR, Bombeiro AL, Bucci DZ, et al. IFN gamma, but not nitric oxide or specific IgG, is essential for the in vivo control of low-virulence Sylvio X10\/4 Trypanosoma cruzi parasites. Scand J Immunol. 2007;66:297\u2013308.","journal-title":"Scand J Immunol"},{"key":"1004_CR13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.femsim.2004.02.003","volume":"41","author":"E Roggero","year":"2004","unstructured":"Roggero E, Piazzon I, Nepomnaschy I, Perez A, Velikovsky A, Revelli S, et al. Thymocyte depletion during acute Trypanosoma cruzi infection in C57BL\/6 mice is partly reverted by lipopolysaccharide pretreatment. FEMS Immunol Med Microbiol. 2004;41:123\u201331.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"1","key":"1004_CR14","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3343\/alm.2018.38.1.9","volume":"38","author":"Z Shang","year":"2018","unstructured":"Shang Z, Wang J, Kuai S, et al. Serum macrophage migration inhibitory factor as a biomarker of active pulmonary tuberculosis [J]. Annals of laboratory medicine. 2018;38(1):9\u201316.","journal-title":"Annals of laboratory medicine"},{"issue":"3","key":"1004_CR15","doi-asserted-by":"crossref","first-page":"222","DOI":"10.3109\/23744235.2015.1107188","volume":"48","author":"SG Kuai","year":"2016","unstructured":"Kuai SG, Ou QF, You DH, et al. Functional polymorphisms in the gene encoding macrophage migration inhibitory factor (MIF) are associated with active pulmonary tuberculosis [J]. Infectious Diseases. 2016;48(3):222\u20138.","journal-title":"Infectious Diseases"},{"key":"1004_CR16","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1164\/ajrccm\/142.3.725","volume":"142","author":"American Thoracic Society","year":"1990","unstructured":"American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis. 1990;142:725\u201335.","journal-title":"Am Rev Respir Dis"},{"issue":"5","key":"1004_CR17","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jinf.2013.12.012","volume":"68","author":"CT Huang","year":"2014","unstructured":"Huang CT, Lee LN, Ho CC, et al. High serum levels of procalcitonin and soluble TREM-1 correlated with poor prognosis in pulmonary tuberculosis [J]. J Infect. 2014;68(5):440\u20137.","journal-title":"J Infect"},{"key":"1004_CR18","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1086\/378273","volume":"37","author":"JA Crump","year":"2003","unstructured":"Crump JA, Reller LB. Two decades of disseminated tuberculosis at a university medical center: the expanding role of mycobacterial blood culture. Clin Infect Dis. 2003;37:1037\u201343.","journal-title":"Clin Infect Dis"},{"key":"1004_CR19","volume-title":"Classification of pulmonary tuberculosis","author":"AJ Falk","year":"1969","unstructured":"Falk AJ, O\u2019Connor B, Pratt PC. Classification of pulmonary tuberculosis. 12th ed. New York: National Tuberculosis and Respiratory Disease Association; 1969.","edition":"12"},{"key":"1004_CR20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","volume":"336","author":"MJ Fine","year":"1997","unstructured":"Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med. 1997;336:243\u201350.","journal-title":"N Engl J Med"},{"key":"1004_CR21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","volume":"27","author":"MJ Pencina","year":"2008","unstructured":"Pencina MJ, D\u2019Agostino RB Sr, D\u2019Agostino RB Jr, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157\u201372.","journal-title":"Stat Med"},{"key":"1004_CR22","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.1007\/s10406-004-0089-y","volume":"14","author":"SM Ellis","year":"2004","unstructured":"Ellis SM. The spectrum of tuberculosis and non-tuberculous mycobacterial infection. Eur Radiol. 2004;14:E34\u201342.","journal-title":"Eur Radiol"},{"key":"1004_CR23","first-page":"213","volume":"19","author":"S Sharma","year":"2001","unstructured":"Sharma S, Bose M. Role of cytokines in immune response to pulmonary tuberculosis. Asian Pac J Allergy Immunol. 2001;19:213\u20139.","journal-title":"Asian Pac J Allergy Immunol"},{"issue":"1","key":"1004_CR24","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41598-017-00299-1","volume":"7","author":"X Tong","year":"2017","unstructured":"Tong X, Yan Z, Zhou Q, et al. Association between the MIF-173G\/C polymorphism and serum MIF levels with pulmonary tuberculosis: a meta-analysis [J]. Sci Rep. 2017;7(1):234.","journal-title":"Sci Rep"},{"key":"1004_CR25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1600-065X.2008.00702.x","volume":"226","author":"AM Cooper","year":"2008","unstructured":"Cooper AM, Khader SA. The role of cytokines in the initiation, expansion,and control of cellular immunity to tuberculosis. Immunol Rev. 2008;226:191\u2013204.","journal-title":"Immunol Rev"},{"key":"1004_CR26","first-page":"98","volume":"9","author":"F Ameglio","year":"2005","unstructured":"Ameglio F, Casarini M, Capoluongo E, Mattia P, Puglisi G, Giosue S. Post-treatment changes of six cytokines in active pulmonary tuberculosis: differences between patients with stable or increased fibrosis. Int J Tuberc Lung Dis. 2005;9:98\u2013104.","journal-title":"Int J Tuberc Lung Dis"},{"key":"1004_CR27","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S1472-9792(02)00054-9","volume":"83","author":"WH Boom","year":"2003","unstructured":"Boom WH, Canaday DH, Fulton SA, Gehring AJ, Rojas RE, Torres M. Human immunity to M. Tuberculosis: T cell subsets and antigen processing. Tuberculosis. 2003;83:98\u2013106.","journal-title":"Tuberculosis"},{"key":"1004_CR28","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0008-8749(91)90014-3","volume":"132","author":"M Denis","year":"1991","unstructured":"Denis M. Interferon-gamma-treated murine macrophages inhibit growth of tubercle bacilli via the generation of reactive nitrogen intermediates. Cell Immunol. 1991;132:150\u20137.","journal-title":"Cell Immunol"},{"key":"1004_CR29","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.cell.2004.11.038","volume":"119","author":"MG Gutierrez","year":"2004","unstructured":"Gutierrez MG, Master SS, Singh SB, Taylor GA, Colombo MI, Deretic V. Autophagy is a defense mechanism inhibiting BCG and mycobacterium tuberculosis survival in infected macrophages. Cell. 2004;119:753\u201366.","journal-title":"Cell"},{"key":"1004_CR30","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1183\/09031936.00174907","volume":"32","author":"DK Kim","year":"2008","unstructured":"Kim DK, Kim HJ, Kwon SY, et al. Nutritional deficit as a negative prognostic factor in patients with military tuberculosis. Eur Respir J. 2008;32:1031\u20136.","journal-title":"Eur Respir J"},{"key":"1004_CR31","first-page":"1360","volume":"10","author":"ED Matos","year":"2006","unstructured":"Matos ED, Moreira Lemos AC. Association between serum albumin levels and in-hospital deaths due to tuberculosis. Int J Tuberc Lung Dis. 2006;10:1360\u20136.","journal-title":"Int J Tuberc Lung Dis"},{"issue":"2","key":"1004_CR32","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1183\/09031936.00011910","volume":"37","author":"M Ugajin","year":"2011","unstructured":"Ugajin M, Miwa S, Shirai M, et al. Usefulness of serum procalcitonin levels in pulmonary tuberculosis [J]. Eur Respir J. 2011;37(2):371\u20135.","journal-title":"Eur Respir J"},{"issue":"9","key":"1004_CR33","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.5588\/ijtld.17.0078","volume":"21","author":"C Yoon","year":"2017","unstructured":"Yoon C, Chaisson LH, Patel SM, et al. Diagnostic accuracy of C-reactive protein for active pulmonary tuberculosis: a meta-analysis [J]. Int. J. Tuberc. Lung Dis. 2017;21(9):1013\u20139.","journal-title":"Int. J. Tuberc. Lung Dis."},{"issue":"1","key":"1004_CR34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molimm.2014.06.002","volume":"62","author":"IH Chowdhury","year":"2014","unstructured":"Chowdhury IH, Ahmed AM, Choudhuri S, et al. Alteration of serum inflammatory cytokines in active pulmonary tuberculosis following anti-tuberculosis drug therapy [J]. Mol Immunol. 2014;62(1):159\u201368.","journal-title":"Mol Immunol"},{"key":"1004_CR35","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cyto.2016.02.003","volume":"81","author":"S Chandrashekara","year":"2016","unstructured":"Chandrashekara S, Anupama KR, Sambarey A, et al. High IL-6 and low IL-15 levels mark the presence of TB infection: a preliminary study [J]. Cytokine. 2016;81:57\u201362.","journal-title":"Cytokine"},{"issue":"32","key":"1004_CR36","doi-asserted-by":"crossref","first-page":"E2997","DOI":"10.1073\/pnas.1301128110","volume":"110","author":"R Das","year":"2013","unstructured":"Das R, Koo MS, Kim BH, et al. Macrophage migration inhibitory factor (MIF) is a critical mediator of the innate immune response to mycobacterium tuberculosis [J]. Proc Natl Acad Sci. 2013;110(32):E2997\u20133006.","journal-title":"Proc Natl Acad Sci"},{"key":"1004_CR37","first-page":"117","volume":"14","author":"M Hashemi","year":"2015","unstructured":"Hashemi M, Sharifi-Mood B, Rasouli A, et al. Macrophage migration inhibitory factor-173 G\/C polymorphism is associated with an increased risk of pulmonary tuberculosis in Zahedan, Southeast Iran [J]. EXCLI J. 2015;14:117.","journal-title":"EXCLI J"},{"issue":"4","key":"1004_CR38","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1673-8527(09)60044-8","volume":"37","author":"K Sadki","year":"2010","unstructured":"Sadki K, Lamsyah H, Rueda B, et al. Analysis of MIF, FCGR2A and FCGR3A gene polymorphisms with susceptibility to pulmonary tuberculosis in Moroccan population [J]. J. Genet. Genomics. 2010;37(4):257\u201364.","journal-title":"J. Genet. Genomics"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1004-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-019-1004-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-1004-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,5]],"date-time":"2020-03-05T00:07:48Z","timestamp":1583366868000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-019-1004-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,6]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["1004"],"URL":"https:\/\/doi.org\/10.1186\/s12931-019-1004-3","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,6]]},"assertion":[{"value":"13 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Written informed consents were obtained from all patients; and, this study conformed to the principles of the Declaration of Helsinki was approved by the investigational review board of the Xinxiang Medical University.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"50"}}